Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Total Neoadjuvant Therapy”

154 trials

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 154 results

Testing effectiveness (Phase 2)Looking for participantsNCT05851924
What this trial is testing

NALIRIFOX in Combination With Radiation Therapy in People With Pancreatic Ductal Adenocarcinoma (PDAC)

Who this might be right for
Pancreatic Ductal Adenocarcinoma
Memorial Sloan Kettering Cancer Center 60
Not applicableWithdrawnNCT04670588
What this trial is testing

Response Assessment by Circulating Tumor DNA in Patients With Locally Advanced Rectal Cancer

Who this might be right for
Rectal Cancer
Medical College of Wisconsin
Testing effectiveness (Phase 2)Looking for participantsNCT07198165
What this trial is testing

SCRT Followed by CAPOX + Bev ± PD-1 Inhibitor for TNT in LARC

Who this might be right for
Rectal CancerRectal AdenocarcinomaRectal Cancer, Radiotherapy+6 more
Ruijin Hospital 104
Testing effectiveness (Phase 2)Study completedNCT00589472
What this trial is testing

Androgen Deprivation Therapy and Vorinostat Followed by Radical Prostatectomy in Treating Patients With Localized Prostate Cancer

Who this might be right for
Prostate AdenocarcinomaStage I Prostate CancerStage IIA Prostate Cancer+2 more
National Cancer Institute (NCI) 19
Early research (Phase 1)UnknownNCT04906044
What this trial is testing

Total Neoadjuvant Treatment Plus PD-1 in Mid-Low Locally Advanced Rectal Cancer

Who this might be right for
TislelizumabLocally Advanced Rectal CancerTotal Neoadjuvant Treatment+1 more
The First Hospital of Jilin University 46
Not applicableActive Not RecruitingNCT05524012
What this trial is testing

Longitudinal Multimodal Response Assessment During Neoadjuvant Treatment of Rectal Cancer

Who this might be right for
Locally Advanced Rectal CarcinomaNeoadjuvant TreatmentRadiotherapy+1 more
Jena University Hospital 40
Testing effectiveness (Phase 2)Looking for participantsNCT06793137
What this trial is testing

Intestinal Microbiome Modulation With Antibiotics in the Neoadjuvant Treatment of Locally Advanced Rectal Cancer

Who this might be right for
Rectal Cancer, Adenocarcinoma
AC Camargo Cancer Center 100
Testing effectiveness (Phase 2)Not Yet RecruitingNCT05969847
What this trial is testing

Organ Preservation Following Enverolimab-based Total Neoadjuvant Therapy for Locally Advanced Very Low Rectal Cancer

Who this might be right for
Rectal Cancer
池畔 72
Testing effectiveness (Phase 2)Study completedNCT02864849
What this trial is testing

Total Neoadjuvant Induction and Consolidation CapeOX Plus IMRT With Capecitabine for MRI Defined High-risk Rectal Cancer

Who this might be right for
Rectal Cancer
Peking University Cancer Hospital & Institute 81
Not applicableActive Not RecruitingNCT05674422
What this trial is testing

GEMCAD-REVEAL STUDY - Circulating Tumor DNA as a Predictor of Relapse in Patients With Locally Advanced Rectal Cancer.

Who this might be right for
Patients With Locally Advanced Rectal Cancer
Grupo Espanol Multidisciplinario del Cancer Digestivo 120
Not applicableLooking for participantsNCT07730541
What this trial is testing

Hyperpolarized 13C-MRI and Radiomics in Rectal Cancer

Who this might be right for
Neoadjuvant Chemoradiotherapy
Chang Gung Memorial Hospital 30
Testing effectiveness (Phase 2)Active Not RecruitingNCT05253846
What this trial is testing

Short-course Radiotherapy Followed by Consolidation Chemotherapy. 2021-001206-29

Who this might be right for
Locally Advanced Rectal Cancer
Gruppo Oncologico del Nord-Ovest 63
Testing effectiveness (Phase 2)UnknownNCT03038256
What this trial is testing

Effect of Concurrent Capecitabine-based Long-term Radiotherapy Followed by XELOX Plus TME in Patients With High Risk Rectal Cancer: a Multi-centers, Randomized Controlled, Open-Label Trial

Who this might be right for
Rectal CancerPathological Complete ResponseDisease Free Survival
Peking University People's Hospital 244
Not applicableNot Yet RecruitingNCT07258797
What this trial is testing

Short Course or Long Course Radiotherapy as Total Neoadjuvant Therapy in Locally Advanced Rectal Cancer

Who this might be right for
Adenocarcinoma of the Rectum
Rajiv Gandhi Cancer Institute & Research Center, India 150
Testing effectiveness (Phase 2)UnknownNCT03729687
What this trial is testing

Short Course Radiation Therapy Followed by Pre-operative Chemotherapy and Surgery in High-risk Rectal Cancer

Who this might be right for
Rectal Cancer
Uppsala University 280
Testing effectiveness (Phase 2)Looking for participantsNCT06162650
What this trial is testing

Total Neoadjuvant Therapy in Rectal Cancer

Who this might be right for
Rectal Cancer
National Cheng-Kung University Hospital 42
Testing effectiveness (Phase 2)UnknownNCT06593899
What this trial is testing

The Total Neoadjuvant Therapy for Soft Tissue Sarcoma of the Extremities

Who this might be right for
Soft Tissue Sarcomas
Fujian Medical University Union Hospital 51
Testing effectiveness (Phase 2)Looking for participantsNCT07095439
What this trial is testing

Efficacy and Toxicity of Total Neoadjuvant Sandwich Treatment Via Short Course Radiotherapy in the Treatment of Stage II and III Rectal Cancer Patients

Who this might be right for
Rectal Cancer
Ain Shams University 38
Testing effectiveness (Phase 2)Active Not RecruitingNCT02008656
What this trial is testing

Trial Evaluating 3-year Disease Free Survival in Patients With Locally Advanced Rectal Cancer Treated With Chemoradiation Plus Induction or Consolidation Chemotherapy and Total Mesorectal Excision or Non-operative Management

Who this might be right for
Rectal Cancer
Memorial Sloan Kettering Cancer Center 358
Large-scale testing (Phase 3)Study completedNCT00767286
What this trial is testing

Goserelin, Flutamine, and Radiation Therapy in Treating Patients With Locally Advanced Prostate Cancer

Who this might be right for
Prostate Cancer
Radiation Therapy Oncology Group
Next Page